Startups
OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors and inflammation.
Overview
Location
Austria, Lower Austria
Employees
11-50
Total raised
$13.85M
Founded date
2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 17, 2021 | OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF | NANJING, China, Nov. 17, 2021 /PRNewswire/ -- OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and GenScript ProBio, a leading CDMO in biologics and gene cell therapy, today announ... |
| Mar 19, 2020 | OncoOne Raises €13M in Series A Funding | OncoOne, a Klosterneuburg, Austria, developer of multiple drug modalities to target oxidized macrophage migration inhibitory factor (oxMIF), raised €13M in Series A funding. Investors included the Austrian Research Promotion Agency (FFG), t... |
| Mar 19, 2020 | Austrian OncoOne launches with €13 million Series A to develop tumor fighting therapeutics | Austrian startup OncoOne has announced closing a €13 million Series A financing round, led by the Austrian Research Promotion Agency (FFG), the Austria Wirtschaftsservice Gesellschaft (AWS), and two family offices. With extensive experience... |
| Mar 18, 2020 | Ex-Shire cancer leader raises cash for solid tumor research | The former head of oncology research at Shire has raised money (PDF) to go after a solid tumor target once pursued by his former employer. Randolf Kerschbaumer, CEO of OncoOne, is working with other ex-Shire employees to target oxidized mac... |
| Mar 18, 2020 | Ex-Shire cancer leader raises cash for solid tumor research W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | The former head of oncology research at Shire has raised money (PDF) to go after a solid tumor target once pursued by his former employer. Randolf Kerschbaumer, CEO of OncoOne, is working with other ex-Shire employees to target oxidized mac... |
Reviews 0
FAQ about OncoOne
When was OncoOne founded?
OncoOne was founded in 2018.
How much funding has OncoOne raised?
OncoOne has raised $13.85M in total across 1 funding round.
What has the press written about OncoOne?
Parsers VC has collected 6 articles mentioning OncoOne, among them “OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF” (Nov 17, 2021) and “OncoOne Raises €13M in Series A Funding” (Mar 19, 2020).
Is OncoOne still active?
Yes, OncoOne is active; its latest activity on Parsers VC dates from Nov 17, 2021.